ANI PHARMACEUTICALS, INC (ANIP) Share buybacks
- Total buybacks · last 12 months (USD): Value $22.22M; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-06-30..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-06-30..
Share buybacks
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $22.22M | Trailing-year cash paid for share repurchases. Period ending 2026-06-30. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 22.22M USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-06-30 | $22.22M | (m) | (m) |
| 2026-03-31 | $21.96M | (m) | (m) |
| 2025-12-31 | $12.21M | (m) | (m) |
| 2025-09-30 | $11.92M | (m) | (m) |
| 2025-06-30 | $11.55M | (m) | (m) |
| 2025-03-31 | $12.30M | (m) | (m) |
| 2024-12-31 | $10.96M | (m) | (m) |
| 2024-09-30 | $10.87M | (m) | (m) |
| 2024-06-30 | $10.86M | (m) | (m) |
| 2024-03-31 | $10.10M | (m) | (m) |
| 2023-12-31 | $4.99M | (m) | (m) |
| 2023-09-30 | $4.88M | (m) | (m) |
| 2023-06-30 | $4.44M | (m) | (m) |
| 2023-03-31 | $4.39M | (m) | (m) |
| 2022-12-31 | $1.96M | (m) | (m) |
| 2022-09-30 | $1.84M | (m) | (m) |
| 2022-06-30 | $1.68M | (m) | (m) |
| 2022-03-31 | $1.66M | (m) | (m) |
| 2021-12-31 | $890.00K | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) |
| 2020-12-31 | $1.52M | (m) | (m) |
| 2019-12-31 | $1.03M | (m) | (m) |
| 2018-12-31 | $0.00 | (m) | (m) |
| 2017-12-31 | $0.00 | (m) | (m) |
| 2017-09-30 | $0.00 | (m) | (m) |
| 2017-06-30 | $0.00 | (m) | (m) |
| 2017-03-31 | $0.00 | (m) | (m) |
| 2016-12-31 | $2.50M | (m) | (m) |
| 2016-09-30 | $2.61M | (m) | (m) |
| 2016-06-30 | $2.61M | (m) | (m) |
| 2016-03-31 | $2.61M | (m) | (m) |
| 2015-12-31 | $113.00K | (m) | (m) |
| 2015-09-30 | $0.00 | (m) | (m) |
| 2015-06-30 | $113.00K | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) |
| 2014-12-31 | $0.00 | (m) | (m) |
| 2014-09-30 | $0.00 | (m) | (m) |
| 2014-06-30 | $0.00 | (m) | (m) |
| 2013-12-31 | $433.00K | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) |
| 2012-12-31 | $0.00 | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |